Literature DB >> 6110804

[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].

W Schmitz.   

Abstract

Newer antiarrhythmic drugs are tentatively classified on the basis of their influence on the transmembrane action potential, the fast sodium inward current and its kinetics, and the slow inward current which is primarily carried by calcium ions. Disopyramide is probably a quinidine-like antiarrhythmic drug, while the effects of aprindine, lorcainide, and tocainide resemble those of lidocaine. Mexiletine and propafenon cannot be classified definitely on the basis of the hitherto available electrophysiological data. Besides their effects on the fast inward current these substances may have additional calcium antagonistic properties.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110804     DOI: 10.1007/bf01477048

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  71 in total

1.  Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.

Authors:  B F Hoffman; M R Rosen; A L Wit
Journal:  Am Heart J       Date:  1975-06       Impact factor: 4.749

2.  Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-09-28       Impact factor: 5.182

Review 3.  Electrophysiology and pharmacology of cardiac arrhythmias. I. Cellular electrophysiology of the mammalian heart.

Authors:  M R Rosen; A L Wit; B F Hoffman
Journal:  Am Heart J       Date:  1974-09       Impact factor: 4.749

4.  Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog.

Authors:  D P Zipes; J C Fischer
Journal:  Circ Res       Date:  1974-02       Impact factor: 17.367

5.  [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].

Authors:  H J Hapke; E Prigge
Journal:  Arzneimittelforschung       Date:  1976

6.  Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel".

Authors:  N El-Sherif; R Lazzara
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

7.  Disopyramide phosphate (Norpace): a new antiarrhythmic drug.

Authors:  P N Yu
Journal:  Circulation       Date:  1979-02       Impact factor: 29.690

8.  Clinical electrophysiologic effects of tocainide.

Authors:  J L Anderson; J W Mason; R A Winkle; P J Meffin; R E Fowles; L Peters; D C Harrison
Journal:  Circulation       Date:  1978-04       Impact factor: 29.690

9.  Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.

Authors:  E Carmeliet; P A Janssen; R Marsboom; J M Van Nueten; R Xhonneux
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-01

Review 10.  Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias b. Re-entry. Section II.

Authors:  A L Wit; M R Rosen; B F Hoffman
Journal:  Am Heart J       Date:  1974-12       Impact factor: 4.749

View more
  1 in total

1.  Effects on transmembrane action potential, slow inward current and force of contraction in ventricular cardiac muscle of BRL 31660, a new antiarrhythmic drug with class I and class IV activity.

Authors:  R Brückner; W Schmitz; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.